Olaparib, a new hope for ovarian cancer

被引:0
|
作者
Samoon, Zarka [1 ]
Jabbar, Adnan Abdul [1 ]
机构
[1] Aga Khan Univ Hosp, Dept Oncol, Karachi, Pakistan
关键词
MAINTENANCE THERAPY; PHASE-2; PARP;
D O I
10.4103/ijc.IJC_1_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:346 / 347
页数:2
相关论文
共 50 条
  • [1] New Biologic Frontiers in Ovarian Cancer: Olaparib Update
    Previs, Rebecca A.
    Dalton, Heather J.
    Coleman, Robert L.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2016, 12 (11) : 14 - 22
  • [2] New hope in therapy of ovarian cancer
    Wagner, U
    Pfisterer, J
    Jackisch, C
    Meier, W
    du Bois, A
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2004, 64 (08) : 777 - 780
  • [3] Olaparib for the treatment of ovarian cancer
    Lheureux, Stephanie
    Oza, Amit M.
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (05): : 497 - 508
  • [4] Olaparib in the treatment of ovarian cancer
    Washington, Christina R.
    Richardson, Debra L.
    Moore, Kathleen N.
    FUTURE ONCOLOGY, 2019, 15 (30) : 3435 - 3449
  • [5] OLAPARIB FOR THE TREATMENT OF OVARIAN CANCER
    Bornstein, E.
    Jimeno, A.
    DRUGS OF TODAY, 2016, 52 (01) : 17 - 28
  • [6] Olaparib in the management of ovarian cancer
    Bixel, Kristin
    Hays, John L.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2015, 8 : 127 - 135
  • [7] New Biologic Frontiers in Ovarian Cancer: Olaparib and PARP Inhibition
    Dalton, Heather J.
    Coleman, Robert L.
    AMERICAN JOURNAL OF HEMATOLOGY-ONCOLOGY, 2015, 11 (05) : 5 - 12
  • [8] Olaparib for the treatment of epithelial ovarian cancer
    McLachlan, Jennifer
    Banerjee, Susana
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 995 - 1003
  • [9] Olaparib Approved for Advanced Ovarian Cancer
    不详
    CANCER DISCOVERY, 2015, 5 (03) : 218 - 218
  • [10] New drug approval: Olaparib and niraparib first line in ovarian cancer
    Delaye, Matthieu
    Rodrigues, Manuel
    BULLETIN DU CANCER, 2021, 108 (04) : 350 - 351